These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 34069176)

  • 21. Hepatocyte-specific Keap1 deletion reduces liver steatosis but not inflammation during non-alcoholic steatohepatitis development.
    Ramadori P; Drescher H; Erschfeld S; Schumacher F; Berger C; Fragoulis A; Schenkel J; Kensler TW; Wruck CJ; Trautwein C; Kroy DC; Streetz KL
    Free Radic Biol Med; 2016 Feb; 91():114-26. PubMed ID: 26698665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ellagic acid ameliorates oxidative stress and insulin resistance in high glucose-treated HepG2 cells via miR-223/keap1-Nrf2 pathway.
    Ding X; Jian T; Wu Y; Zuo Y; Li J; Lv H; Ma L; Ren B; Zhao L; Li W; Chen J
    Biomed Pharmacother; 2019 Feb; 110():85-94. PubMed ID: 30466006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alpha-naphthoflavone attenuates non-alcoholic fatty liver disease in oleic acid-treated HepG2 hepatocytes and in high fat diet-fed mice.
    Xia H; Zhu X; Zhang X; Jiang H; Li B; Wang Z; Li D; Jin Y
    Biomed Pharmacother; 2019 Oct; 118():109287. PubMed ID: 31401392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dehydroabietic acid improves nonalcoholic fatty liver disease through activating the Keap1/Nrf2-ARE signaling pathway to reduce ferroptosis.
    Gao G; Xie Z; Li EW; Yuan Y; Fu Y; Wang P; Zhang X; Qiao Y; Xu J; Hölscher C; Wang H; Zhang Z
    J Nat Med; 2021 Jun; 75(3):540-552. PubMed ID: 33590347
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Liu YL; Lin LC; Tung YT; Ho ST; Chen YL; Lin CC; Wu JH
    Int J Med Sci; 2017; 14(9):862-870. PubMed ID: 28824323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reverse pharmacology of Nimbin-N2 attenuates alcoholic liver injury and promotes the hepatoprotective dual role of improving lipid metabolism and downregulating the levels of inflammatory cytokines in zebrafish larval model.
    Sudhakaran G; Prathap P; Guru A; Haridevamuthu B; Murugan R; Almutairi BO; Almutairi MH; Juliet A; Gopinath P; Arockiaraj J
    Mol Cell Biochem; 2022 Oct; 477(10):2387-2401. PubMed ID: 35575874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipid Modulating Anti-oxidant Stress Activity of Gastrodin on Nonalcoholic Fatty Liver Disease Larval Zebrafish Model.
    Ahmad O; Wang B; Ma K; Deng Y; Li M; Yang L; Yang Y; Zhao J; Cheng L; Zhou Q; Shang J
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31018538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-Alcoholic Fatty Liver Disease.
    Engin A
    Adv Exp Med Biol; 2017; 960():443-467. PubMed ID: 28585211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Limonin Alleviates Non-alcoholic Fatty Liver Disease by Reducing Lipid Accumulation, Suppressing Inflammation and Oxidative Stress.
    Li Y; Yang M; Lin H; Yan W; Deng G; Ye H; Shi H; Wu C; Ma G; Xu S; Tan Q; Gao Z; Gao L
    Front Pharmacol; 2021; 12():801730. PubMed ID: 35046824
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    Han J; Dong J; Zhang R; Zhang X; Chen M; Fan X; Li M; Li J; Zhu J; Shang J; Yue Y
    Mediators Inflamm; 2021; 2021():9951946. PubMed ID: 34475805
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SGL 121 Attenuates Nonalcoholic Fatty Liver Disease through Adjusting Lipid Metabolism Through AMPK Signaling Pathway.
    Kim DE; Chang BY; Jeon BM; Baek JI; Kim SC; Kim SY
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32630596
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Acupuncture improves hepatic lipid metabolism by suppressing oxidative stress in obese nonalcoholic fatty liver disease rats].
    Wang HY; Liang CM; Cui JW; Pan L; Hu H; Fang HJ
    Zhen Ci Yan Jiu; 2019 Mar; 44(3):189-94. PubMed ID: 30945501
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    Han JH; Park MH; Myung CS
    Antioxidants (Basel); 2021 Jul; 10(8):. PubMed ID: 34439474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alisol A 24-Acetate Prevents Hepatic Steatosis and Metabolic Disorders in HepG2 Cells.
    Zeng L; Tang W; Yin J; Feng L; Li Y; Yao X; Zhou B
    Cell Physiol Biochem; 2016; 40(3-4):453-464. PubMed ID: 27889747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mitochondrial gene polymorphisms alter hepatic cellular energy metabolism and aggravate diet-induced non-alcoholic steatohepatitis.
    Schröder T; Kucharczyk D; Bär F; Pagel R; Derer S; Jendrek ST; Sünderhauf A; Brethack AK; Hirose M; Möller S; Künstner A; Bischof J; Weyers I; Heeren J; Koczan D; Schmid SM; Divanovic S; Giles DA; Adamski J; Fellermann K; Lehnert H; Köhl J; Ibrahim S; Sina C
    Mol Metab; 2016 Apr; 5(4):283-295. PubMed ID: 27069868
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peroxiredoxin 5 ameliorates obesity-induced non-alcoholic fatty liver disease through the regulation of oxidative stress and AMP-activated protein kinase signaling.
    Kim MH; Seong JB; Huh JW; Bae YC; Lee HS; Lee DS
    Redox Biol; 2020 Jan; 28():101315. PubMed ID: 31505325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Water Extract of
    Mun J; Kim S; Yoon HG; You Y; Kim OK; Choi KC; Lee YH; Lee J; Park J; Jun W
    Nutrients; 2019 Oct; 11(10):. PubMed ID: 31640183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of ClC-2 Alleviates High Fat Diet-Induced Insulin Resistance and Non-Alcoholic Fatty Liver Disease.
    Fu D; Cui H; Zhang Y
    Cell Physiol Biochem; 2018; 45(6):2187-2198. PubMed ID: 29550812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pinolenic acid ameliorates oleic acid-induced lipogenesis and oxidative stress via AMPK/SIRT1 signaling pathway in HepG2 cells.
    Zhang J; Zhang SD; Wang P; Guo N; Wang W; Yao LP; Yang Q; Efferth T; Jiao J; Fu YJ
    Eur J Pharmacol; 2019 Oct; 861():172618. PubMed ID: 31430456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cellular cholesterol accumulation modulates high fat high sucrose (HFHS) diet-induced ER stress and hepatic inflammasome activation in the development of non-alcoholic steatohepatitis.
    Bashiri A; Nesan D; Tavallaee G; Sue-Chue-Lam I; Chien K; Maguire GF; Naples M; Zhang J; Magomedova L; Adeli K; Cummins CL; Ng DS
    Biochim Biophys Acta; 2016 Jul; 1861(7):594-605. PubMed ID: 27090939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.